Caris Life Sciences to Attend Q4 2025 Investor Conferences

Accessibility StatementSkip Navigation IRVING, Texas, Nov. 17, 2025 /PRNewswire/ -- Caris Life Sciences®Â (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the company will attend the following investor conferences: Contact [email protected] to schedule meetings. About Caris Life SciencesCaris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is acti ...